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Objective: To evaluate retrospectively the clinical effectiveness of FlightPlan for Liver (FPFL), an automated tumor-feeding 
artery detection software in cone-beam CT angiography (CBCTA), in identifying tumor-feeding arteries for the treatment of 
hepatocellular carcinoma (HCC) using three different segmentation sensitivities.
Materials and Methods: The study included 50 patients with 80 HCC nodules who received transarterial chemoembolization. 
Standard digital subtracted angiography (DSA) and CBCTA were systematically performed and analyzed. Three settings of the 
FPFL software for vascular tree segmentation were tested for each tumor: the default, Group D; adjusting the proportion of 
segmented tumor area between 30 to 50%, Group L; and between 50 to 80%, Group H.
Results: In total, 109 feeder vessels supplying 80 HCC nodules were identified. The negative predictive value of DSA, FPFL 
in groups D, L, and H was 56.8%, 87.7%, 94.2%, 98.5%, respectively. The accuracy of DSA, FPFL in groups D, L, and H was 
62.6%, 86.8%, 93.4%, 95.6%, respectively. The sensitivity, negative predictive value (NPV), and accuracy of FPFL were 
higher in Group H than in Group D (p = 0.041, 0.034, 0.005). All three segmentation sensitivity groups showed higher 
specificity, positive predictive value, NPV, and accuracy of FPFL, as compared to DSA.
Conclusion: FlightPlan for Liver is a valuable tool for increasing detection of HCC tumor feeding vessels, as compared to 
standard DSA analysis, particularly in small HCC. Manual adjustment of segmentation sensitivity improves the accuracy of 
FPFL.
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INTRODUCTION
Transarterial chemoembolization (TACE), first introduced 
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in Japan, is now well established for managing unresectable 
hepatocellular carcinomas (HCC) showing prominent 
hypervascular staining on angiography due to rich arterial 
blood supply (1). The purpose of TACE is to deliver high 
concentrations of drug to the tumor, while preserving the 
surrounding liver parenchyma. Various embolization methods 
are used to increase drug delivery to tumor, including 
gelatin sponges and drug eluting beads (2, 3). The principal 
of TACE is selective delivery of chemotherapeutic agents to 
the tumor to achieve better outcomes (4, 5).
Two-dimensional (2D) digital subtraction angiography 
(DSA) is traditionally used to identify tumor-feeding 
arteries and serves as a roadmap to guide the microcatheter 
to the desired injection point. Recent improvements in 
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All patients were previously diagnosed with chronic 
viral hepatitis or liver cirrhosis: hepatitis B in 38 patients, 
hepatitis C in 5 patients, and unknown etiology in 7 
patients. All HCCs were diagnosed based on the imaging 
findings from computed tomography (CT) or magnetic 
resonance imaging (MRI).
Twenty patients had > 1 HCC nodule, so a total 80 HCC 
nodules (mean diameter 20.8 mm) were included. Of these, 
6 had a diameter ≥ 4 cm, 7 in the 3–4 cm range, 15 in the 
2–3 cm range and 52 < 2 cm, and 67 HCC nodules in 44 
patients ≤ 30 mm. The mean diameter of HCC nodules was 
15.2 ± 5.4 mm.
Imaging Protocol
Angiography was performed under local anesthesia. A 5-Fr 
angiographic sheath was inserted into the right common 
femoral artery, and a 5-Fr Yashiro catheter (A&A MD, 
Seongnam, Korea) and a 0.035-inch hydrophilic guidewire 
(Terumo, Tokyo, Japan) were used to cannulate the common 
hepatic artery. A flat-panel detector C-arm angiography 
system (Innova IGS 540, GE Healthcare, Chalfont St. Giles, 
UK) were used to acquire DSA and CBCTA images from the 
same location during injection of contrast media (iodixanol 
[Visipaque] 320 mgI/mL; GE Healthcare) while asking the 
patients to hold their breath.
The DSA images were acquired on anterior-posterior 
projection with injection of 18 mL of contrast media at a 
flow rate of 3 mL/sec and a frame rate of 2 images/sec. 
If common hepatic arteriogram could not be performed 
with 5 Fr angiographic catheter due to anatomic variations 
or celiac stenosis, DSA of the right or left hepatic artery 
was performed with a 2.0-Fr tip microcatheter (Progreat; 
Terumo Clinical Supply, Kakamigahara, Japan) or 2.2-
Fr microcatheter (JS microcatheter; A&A MD, Seongnam, 
Korea) with injection of 8–12 mL of contrast media at a 
rate of 1.5 mL/sec.
After DSA, a 3-dimensional (3D) CBCTA was performed 
while in the common or proper hepatic artery with injection 
of 30–36 mL of contrast media at a rate of 3 mL/sec. The 
scan delay was 5–7 seconds; hence, CBCTA was acquired 
5–7 seconds after the start of contrast media injection. 
One hundred and fifty projections were obtained during a 
5 second rotation, over an angular range of 200° (40°/
sec rotation speed). The data sets were automatically 
transferred to a workstation (ADW 4.6, GE Healthcare) for 
reconstruction and analysis. The reconstructed 3D volume is 
a cylinder of 23-cm diameter, and 23-cm height, described 
imaging capabilities, such as cone-beam CT angiography 
(CBCTA) allow interventional radiologists (IRs) to detect 
smaller and less hypervascular HCC (6, 7). However, CBCTA 
with subsequent analysis for superselective or ultraselective 
TACE requires more lengthy analysis of complex vascular 
anatomy than DSA, as the operator is required to analyze 
multiplanar trace of the fine arteries repeatedly, even if 
only single injection of the contrast medium is required (8). 
In practice, the IR needs to leave the sterile angiographic 
room to manipulate the dedicated workstation for CBCTA 
data analysis. Several reports indicate that the use 
of automated software decreases required time while 
maintaining accuracy (9, 10) in CBCTA analysis. Software 
performance is affected by various factors, such as the 
tumor vascularity and diameter, and the vessels visibility in 
CBCTA images.
Although a palliative treatment, the ability to achieve 
initial higher local tumor response rate by superselective or 
ultraselective TACE that initially targets all feeding arteries, 
including the main and minor feeding arteries, is correlated 
to patient prognosis. Iwazawa et al. (11) reported longer 
local progression-free survival in patients treated with 
CBCTA-assisted chemoembolization, as compared to DSA 
only-guided chemoembolization. Their study forms the 
basis for next generation TACE, which avoids missing minor 
feeding arteries and preserves healthy liver from toxicity.
In this study we aimed to comparatively evaluate the 
accuracy of manual identification of tumor-feeding arteries 
in HCC treatment using DSA vs. an automated tumor-
feeding artery detection software (FlightPlan For Liver; GE 
Healthcare, Chalfont St. Giles, UK) using CBCTA under three 
different settings, in order to analyze the impact of each 
setting on the software performance.
MATERIALS AND METHODS
Patient Population
Our Institutional Review Board approved this retrospective 
study. Fifty-two patients with inoperable HCCs who were 
referred for TACE between June 2013 and January 2014 were 
selected. From these 52 patients, 1 was excluded due to 
poor image quality as a result of poor patient cooperation 
during respiratory holding period; 1 patient was excluded 
due to extrahepatic parasites not derived from the common 
hepatic artery or replaced hepatic artery, but originating 
from the right inferior adrenal artery. Finally, 50 patients 
were enrolled in the study.
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in a matrix of 512 x 512 x 512 pixels.
Image Analysis by Automated Tumor-Feeding Artery 
Detection Software
The image analyses related to tumor-feeding branch 
detection were performed during the TACE session by the 
radiologic technician using dedicated software (FlightPlan 
for Liver, GE Healthcare) in 3 consecutive steps:
1) Vascular tree extraction: a seeding point was manually 
deposited at the proximal part of the proper hepatic artery. 
The software enables separation of the hepatic vascular tree 
from other structures (parenchyma, bones). The threshold 
between voxel intensities that are considered vessels was 
manually adjusted for segmenting more or less vessels from 
the background tissues (Fig. 1).
2) Target definition: the radiologic technician used 
multiplanar views (axial, sagittal, and coronal) to designate 
a spherical region of interest (ROI) around the targeted 
tumor. The ROI was adjusted to cover the entire tumor 
excluding the peripheral margin for maximum accuracy, 
based on the study by Iwazawa et al. (10).
3) Feeding artery selection: once proximal point and 
target ROI were defined, the software automatically 
extracted all vessels in the vicinity of the target, and 
highlighted them in a different color.
FlightPlan for Liver software settings for vascular tree 
segmentation were categorized into 3 groups to analyze the 
impact of the initial segmentation step: default setting, 
Group D; manual adjustment of the proportion of segmented 
tumor area between 30 to 50%, Group L; and between 50 to 
80%, Group H.
Four groups of tumor feeding artery candidates were 
defined for each tumor using DSA alone, group D, group L, 




Fig. 1. Segmentation sensitivity step.
A. Basic diagram, black lined structures represent hepatic vessels and black arrowheads indicate true tumor feeding arteries. Red circle represents 
hepatocellular carcinoma and polygonal areas within circle represent mosaic pattern enhancement within tumor. B. During vascular extraction 
process, software separates vascular structures based on threshold between voxel intensities of contrast-filled hepatic arteries and surrounding 
liver parenchyme. Threshold was designated segmentation sensitivity, and separated vascular structures were highlighted with green color (left). 
In ideal condition, FPFL identifies all tumor feeding vessels as purple colored structures (right). C. Low segmentation sensitivity; if threshold is 
too high, small hepatic vessels cannot be separated since size precludes proper contrast enhancement against surrounding liver parenchyma (left). 
Software failed to identify one of tumor feeding vessels (right, white arrowhead) and resulted in false negative. D. High segmentation sensitivity; 
if threshold is too low, liver parenchyme can be misinterpreted as vascular structures (left, gray area). In this setting, software can misidentify 
vicinity vessels as tumor feeding artery and results in false positive (right, black arrow). FPFL = FlightPlan for Liver
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TACE Procedure
All potential tumor feeding branches at the subsegmental 
level of the hepatic artery, were selectively catheterized 
using a 2.0-Fr microcatheter. The artery was considered a 
true feeder if selective angiography or CBCTA after infusion 
of ethiodized oil (Lipiodol; Guerbet, Aulnay-sous-Bois, 
France) revealed partial or entire tumor blush.
After confirming blood supply to the tumor, TACE was 
performed using either conventional TACE (a mixture 
of Lipiodol and doxorubicin [Adriamycin RDF; Ildong 
Pharmaceutical, Seoul, Korea], followed by gelatin sponge 
particles), drug-eluting beads TACE (microspheres such 
as DC bead [Biocompatibles, Farnham, Surrey, UK], or 
Hepasphere [Biosphere Medical, Roissy, France] loaded with 
doxorubicin). Injection was discontinued upon stasis with 
drug-eluting beads or when opacification of portal veins 
was observed during conventional TACE.
Statistical Analysis
The ground truth was defined in consensus by 2 IRs, 
after reviewing all images obtained, during and after TACE, 
and in particular the selective injection of tumor feeder 
candidates.
Of all possible feeding arteries, true positive/negative, 
and false positive/negative tumor feeding arteries, were 
defined in consensus by 2 IRs. Possible tumor feeding 
arteries were the sum of suspected tumor feeding arteries 
on DSA or tumor feeding arteries from FPFL in each group. 
Of these, true positives were defined as vessels confirmed 
by either selective DSA or CBCTA (partial or entire tumor 
blush after infusion of Lipiodol in the suspected vessel); 
false positives were defined as potential feeder arteries 
not confirmed by selective DSA or CBCTA, but considered 
as feeders by either FPFL group D, L, H or DSA alone; 
false negatives were defined as potential feeder arteries 
confirmed by either selective DSA or CBCTA but not found 
using FPFL group D, L, H or DSA analysis; true negatives 
were defined as potential feeder arteries not confirmed 
as feeders using either selective DSA or CBCTA and not 
found as feeders using either FPFL group D, L, H or DSA 
analysis. Subsequently, accuracy, specificity, sensitivity, 
negative predictive value (NPV) and positive predictive 
value (PPV) were computed. A chi-squared test was used for 
multiple comparisons of the 3 FPFL groups, with respect to 
sensitivity, specificity, PPV, NPV, and accuracy. Factors were 
considered statistically significant with a p < 0.05.
RESULTS
Detectability and Correct Identification 
of the Tumor-Feeding Artery with DSA and FPFL
The software and DSA identified 182 possible tumor-
feeding arteries in total, which originated from the common 
hepatic artery or the replaced hepatic artery. Among 
these, 109 feeding vessels were confirmed as true feeding 
branches for HCCs by selective angiography or CBCTA after 
injection of contrast media or Lipiodol. Ninety-three tumor-
feeding vessels (85.3%) were identified with nonselective 
DSA. But, DSA identified a significantly smaller number of 
true negative vessels and a larger number of false positive 
vessels. FPFL showed significantly higher accuracy of tumor-
feeding vessel detection than nonselective DSA, in all 
groups (p < 0.001) (Table 1).
Group D showed a decreased number of true positive 
feeders and an increased number of false positive feeders, 
as compared to Group H, for e.g., 16 false positive tumor-
feeding arteries were found in Group D, as compared to 7 
false positive tumor-feeding arteries in Group H. In general, 
small tumor-feeding arteries were detected by adjusting 
segmentation sensitivity but not default setting (Group 
D) (Figs. 2, 3). The sensitivity of DSA, FPFL in groups D, L 
and H was 85.3%, 92.7%, 96.3%, 99.1%, respectively. The 
NPV of DSA, FPFL in groups D, L, and H was 56.8%, 87.7%, 
94.2%, 98.5%, respectively. The accuracy of DSA, FPFL 
in groups D, L, and H was 62.6%, 86.8%, 93.4%, 95.6%, 
respectively. The sensitivity, NPV, and accuracy of FPFL 
Table 1. Detectability of Tumor Feeding Artery with Computed Software Using Three Sensitivity Threshold in All Patients
DSA
FPFL
Group D Group L Group H 
Sensitivity, % 85.3 (93/109) 92.7 (101/109) 96.3 (105/109) 99.1 (108/109)
Specificity, % 28.8 (21/73) 78.1 (57/73) 89.0 (65/73) 90.4 (66/73)
PPV, % 64.1 (93/145) 86.3 (101/117) 92.9 (105/113) 93.9 (108/115)
NPV, % 56.8 (21/37) 87.7 (57/65) 94.2 (65/69) 98.5 (66/67)
Accuracy, % 62.6 (114/182) 86.8 (158/182) 93.4 (170/182) 95.6 (174/182)
DSA = digital subtraction angiography, FPFL = FlightPlan for Liver, NPV = negative predictive value, PPV = positive predictive value
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were higher in Group H than in Group D (p = 0.041, 0.034, 
0.005). All 3 segmentation sensitivity groups showed higher 
specificity, PPV, NPV, and accuracy of FPFL, as compared to 
DSA.
Detection and Accurate Identification of the 
Tumor-Feeding Artery in HCC Nodules ≤ 30 mm
In the small tumors (n = 67), 81 tumor-feeding arteries 
were identified. DSA showed lower accuracy than FPFL in 
the 3 groups (p < 0.001) (Table 2). There was in sensitivity, 
specificity, PPV, NPV, and accuracy of FPFL showed no 
significant differences between Group L and Group H. 
Specificity (p = 0.034) and accuracy (p = 0.010) of FPFL 
were significantly different between Group D and Group 
L. However, Group D and Group H showed a significant 
difference in sensitivity (p = 0.011), specificity (p = 0.016), 
PPV (p = 0.025), NPV (p = 0.008), and accuracy (p = 0.000) 
of FPFL.
DISCUSSION
Conventional DSA uses 2D frontal and oblique projection 
images to identify tumor-feeding arteries, hence, minor 
feeding arteries could be missed due to overlapping vessels. 
Main feeding arteries that are non-hypertrophic are also 
difficult to find on DSA images. On the contrary, CBCTA 
provides 3D geometry of vessels and liver parenchyma that 
can be helpful in the analysis of the liver arterial tree (12). 
Kakeda et al. (13) reported that additional information 
was available from the CBCTA in 81% patients, indicating 
the benefit of CBCTA over 2D DSA. Virmani et al. (14) 
described that CBCTA provided additional information 
in 39% patients, which led to microcatheter position 
modification when performing TACE. Some reports indicated 
that CBCTA is more accurate than 2D DSA in identification 
of minor feeding arteries (8, 15). Additional CBCTA is 
considered time-consuming (9); however, Iwazawa et al. 
(16) showed that CBCTA in conjunction with FPFL software 
allowed comparable tumor response rate with fewer image 
acquisitions and in less time than DSA alone.
Two studies previously reported that computer aided 
identification of feeding-arteries is both accurate and 
sensitive (9, 16). Moreover, the software is not entirely 
automatic, and Iwazawa et al. (10) previously showed 
the impact of ROI size on accuracy. Thus, the ROI should 
be exactly adjusted to the size of the tumor to maximize 
sensitivity; if the ROI is too small or large, the sensitivity 




Fig. 2. Impact of three settings of FPFL software for vascular tree segmentation on accuracy.
A. Group D corresponded to default segmentation. B. Group L by adjusting proportion of segmented tumor area between 30 to 50%. C. Group 
H by adjusting it between 50 to 80%. Volume-rendered CT images provide possible tumor feeder vessels extracted with each software analysis. 
Default setting (group D) failed to detect feeder originating from segment 4 hepatic artery (white arrow). Group L showed segment 4 hepatic 
artery as possible tumor feeder. Finally, group H clearly displayed direct connection between tumor (red circle) and subsegmental tumor feeder 
(white arrowhead). FPFL = FlightPlan for Liver
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alone.
Herein, we studied the impact of the manual adjustment 
allowed in the software, i.e., threshold during vessel 
segmentation. The results indicated that if the arterial 
enhancement of the tumor is faint or the feeding vessel is 
too small to achieve proper contrast enhancement against 
surrounding liver parenchyma, the segmentation sensitivity 
should be elevated to extract more vessels. But, increasing 
finely tuned segmentation sensitivity also increases 
the false vascular structures; software misinterprets the 
liver parenchyma or beam-hardening artifact as vascular 
structures and decreases the accuracy by increasing false 
positive feeding vessels. Although the current vendor 
provides automated algorithms, various factors can affect 
the accuracy of the threshold. We used the extent of 
highlighted area within target tumor as standard. Under 
our angiography protocols, the default setting (group D) 
showed various segmentation sensitivity, but usually < 50% 
of the target ROI was defined as vascular structures, which 
showed similar sensitivity with group L. But in some cases, 
especially in small HCC, the segmentation sensitivity of 




Fig. 3. Images from patient with hepatocellular carcinoma undergoing transarterial chemoembolization.
A. DSA obtained at common hepatic artery shows that target tumor is located in S5/6 and faintly enhanced (arrow). B. Group D shows false 
positive feeder artery and selective angiogram of false positive feeder artery does not shows tumor. C. Group H shows true positive feeder artery 
and selective angiogram of true positive feeder artery shows tumor enhancement. DSA = digital subtraction angiography
Table 2. Detectability of Tumor Feeding Artery with Computed Software Using Three Sensitivity Threshold, Especially in Small HCC ≤ 30 mm
DSA
FPFL
Group D Group L Group H 
Sensitivity, % 81.5 (66/81) 90.1 (73/81) 96.3 (78/81) 100.0 (81/81)
Specificity, % 31.2 (19/61) 73.8 (45/61) 90.2 (55/61) 91.8 (56/61)
PPV, % 61.1 (66/108) 82.0 (73/89) 92.9 (78/84) 94.2 (81/86)
NPV, % 55.9 (19/34) 84.9 (45/53) 94.8 (55/58) 100.0 (56/56)
Accuracy, % 59.9 (85/142) 83.1 (118/142) 93.7 (133/142) 96.5 (137/142)
DSA = digital subtraction angiography, FPFL = FlightPlan for Liver, HCC = hepatocellular carcinoma, NPV = negative predictive value,  
PPV = positive predictive value
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false negative or false positive results. We demonstrated 
that increased segmentation sensitivity (group H) in HCC 
nodules < 30 mm has highest accuracy, as compared to 
the other groups. Overall, all FPFL groups showed higher 
accuracy than standard DSA alone. Increased accuracy is 
often compromised by greater numbers of false positives; 
however, the clinical benefit of complete treatment 
outweighs the risk of aggressive TACE.
Lee et al. (17) reported 90% accuracy of CBCTA with 
maximum intensity projection (MIP) and multiplanar 
reformation (MPR) analysis. However, the separation of 
MIP and MIP + MPR suggests that the inexperienced user 
has difficulties in analyzing the CBCTA on MPR basis. In 
our experience, properly adjusted segmentation sensitivity 
of FPFL can shows the accuracy of MPR image in depicting 
tumor and subtle feeding arteries, and served as a 3D 
navigation tool via MIP imaging of the feeding artery. 
In our patient population, 20 HCC nodules were supplied 
by > 1 feeder from a different segmental artery. Usually, the 
main feeding artery is easily identified, but it is difficult 
to detect several minor feeders with nonselective 2D DSA 
because the minor tumor feeding artery is usually non-
hypertrophic. FPFL allows distinguishing feeders including 
minor ones from adjacent hepatic arteries. Each feeder 
can then be exported and overlaid automatically over 
live fluoroscopy, as a 3D roadmap to facilitate the TACE 
procedure (Innova Vision; GE Healthcare).
The current generation of FPFL has several limitations. 
First, the accuracy is affected by the size of the manually 
deposited ROI; also, only spherical shape is currently 
available, which is inappropriate to evaluate irregular 
or ovoid shaped HCCs. Secondly, only one ROI can be 
deposited at a time. In patients with several HCC nodules, 
the process must therefore be repeated. Lastly, all vessels 
in the geometric vicinity of a tumor are not necessarily 
tumor feeding arteries. For example, in a patient with a 
subcapsular HCC nodule located in the segment 3, the 
software misidentified an accessory left gastric artery as 
tumor feeding artery due to its proximity to the tumor. 
This technique depends on good quality CBCTA with 
cooperation of sedated patients for breath holding, 
appropriate injection protocols, and X-ray delays. Moreover, 
only contrast injected vessels are taken into account. So, 
non-injected vessels, such as collateral or parasitic arterial 
supply from extrahepatic sources cannot be detected. 
In conclusion, FPFL is a valuable tool for increasing the 
ability to detect HCC tumor feeding vessels compared to 
standard DSA analysis. It can assist the radiologist in his 
analysis of the complex liver vascular tree, particularly 
identification of small feeders, often difficult to see on DSA. 
Manual adjustment of segmentation sensitivity improves the 
accuracy of FPFL.
REFERENCES
1. Korean Liver Cancer Study Group (KLCSG); National Cancer 
Center, Korea (NCC). 2014 Korean Liver Cancer Study Group-
National Cancer Center Korea practice guideline for the 
management of hepatocellular carcinoma. Korean J Radiol 
2015;16:465-522
2. Liu YS, Ou MC, Tsai YS, Lin XZ, Wang CK, Tsai HM, et al. 
Transarterial chemoembolization using gelatin sponges or 
microspheres plus lipiodol-doxorubicin versus doxorubicin-
loaded beads for the treatment of hepatocellular carcinoma. 
Korean J Radiol 2015;16:125-132
3. Han K, Kim JH, Yoon HM, Kim EJ, Gwon DI, Ko GY, et al. 
Transcatheter arterial chemoembolization for infiltrative 
hepatocellular carcinoma: clinical safety and efficacy 
and factors influencing patient survival. Korean J Radiol 
2014;15:464-471
4. Miyayama S, Matsui O, Yamashiro M, Ryu Y, Kaito K, Ozaki K, 
et al. Ultraselective transcatheter arterial chemoembolization 
with a 2-f tip microcatheter for small hepatocellular 
carcinomas: relationship between local tumor recurrence and 
visualization of the portal vein with iodized oil. J Vasc Interv 
Radiol 2007;18:365-376
5. Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano 
M, Peri E, et al. Efficacy of selective transarterial 
chemoembolization in inducing tumor necrosis in small (<5 
cm) hepatocellular carcinomas. Hepatology 2011;53:1580-
1589
6. Wallace MJ, Murthy R, Kamat PP, Moore T, Rao SH, Ensor J, et 
al. Impact of C-arm CT on hepatic arterial interventions for 
hepatic malignancies. J Vasc Interv Radiol 2007;18:1500-1507
7. Kim HC. Role of C-arm cone-beam CT in chemoembolization 
for hepatocellular carcinoma. Korean J Radiol 2015;16:114-
124
8. Iwazawa J, Ohue S, Mitani T, Abe H, Hashimoto N, Hamuro 
M, et al. Identifying feeding arteries during TACE of hepatic 
tumors: comparison of C-arm CT and digital subtraction 
angiography. AJR Am J Roentgenol 2009;192:1057-1063
9. Deschamps F, Solomon SB, Thornton RH, Rao P, Hakime A, 
Kuoch V, et al. Computed analysis of three-dimensional cone-
beam computed tomography angiography for determination 
of tumor-feeding vessels during chemoembolization of 
liver tumor: a pilot study. Cardiovasc Intervent Radiol 
2010;33:1235-1242
10. Iwazawa J, Ohue S, Hashimoto N, Mitani T. Accuracy of 
software-assisted detection of tumour feeders in transcatheter 
hepatic chemoembolization using three target definition 
778
Joo et al.
Korean J Radiol 17(5), Sep/Oct 2016 kjronline.org
protocols. Clin Radiol 2014;69:145-150
11. Iwazawa J, Ohue S, Hashimoto N, Muramoto O, Mitani 
T. Survival after C-arm CT-assisted chemoembolization 
of unresectable hepatocellular carcinoma. Eur J Radiol 
2012;81:3985-3992
12. Pichon E, Bekes G, Deschamps F, Solomon SB. Development 
and preliminary evaluation of software for planning selective 
liver embolizations from three-dimensional rotational 
fluoroscopy imaging. Int J CARS 2008;3:405-412
13. Kakeda S, Korogi Y, Ohnari N, Moriya J, Oda N, Nishino K, 
et al. Usefulness of cone-beam volume CT with flat panel 
detectors in conjunction with catheter angiography for 
transcatheter arterial embolization. J Vasc Interv Radiol 
2007;18:1508-1516
14. Virmani S, Ryu RK, Sato KT, Lewandowski RJ, Kulik L, Mulcahy 
MF, et al. Effect of C-arm angiographic CT on transcatheter 
arterial chemoembolization of liver tumors. J Vasc Interv 
Radiol 2007;18:1305-1309
15. Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Sugimori 
N, Igarashi S, et al. Usefulness of cone-beam computed 
tomography during ultraselective transcatheter arterial 
chemoembolization for small hepatocellular carcinomas that 
cannot be demonstrated on angiography. Cardiovasc Intervent 
Radiol 2009;32:255-264
16. Iwazawa J, Ohue S, Hashimoto N, Mitani T. Comparison of the 
number of image acquisitions and procedural time required for 
transarterial chemoembolization of hepatocellular carcinoma 
with and without tumor-feeder detection software. Radiol Res 
Pract 2013;2013:580839
17. Lee IJ, Chung JW, Yin YH, Kim HC, Kim YI, Jae HJ, et 
al. Cone-beam computed tomography (CBCT) hepatic 
arteriography in chemoembolization for hepatocellular 
carcinoma: performance depicting tumors and tumor feeders. 
Cardiovasc Intervent Radiol 2015;38:1218-1230
